Sá João Roberto de, Gonzalez Adriano Miziara, Melaragno Cláudio Santiago, Saitovich David, Franco Denise Reis, Rangel Erika Bevilaqua, Noronha Irene Lourdes, Pestana José Osmar Medina, Bertoluci Marcelo Casaccia, Linhares Marcelo, Miranda Marcelo Perosa de, Monteagudo Patricia, Genzini Tércio, Eliaschewitz Freddy Goldberg
Departamento de Cirurgia, Departamento de Medicina, Universidade Federal de São Paulo, SP, Brasil.
Arq Bras Endocrinol Metabol. 2008 Mar;52(2):355-66. doi: 10.1590/s0004-27302008000200024.
Pancreas and kidney transplants have specific indications, benefits and risks. The procedure has become more common and more often as long-term success has improved and risks have decreased. Compared with a patient being on dialysis, simultaneous pancreas-kidney transplant offers a distinct advantage when it comes to mortality, quality of life and diabetic complications. Since there can be a living-donor kidney transplant,, a possibly similar patient and graft survival by 10 years follow-up, this procedure should be considered. Pancreas after kidney transplants, when successful, can improve microvascular complications compared with kidney transplant alone, but immediate mortality may be higher. Solitary pancreas transplantation can improve the quality of life in selected patients, but it may also increase the immediate risk of mortality due to the complexity of the surgery and the risks of immunosupression. The results of Islet transplantation differ from the higher metabolic performance achieved by whole pancreas allotransplantation and its applicability is limited to selected adult diabetic patients.
胰腺和肾脏移植有特定的适应症、益处和风险。随着长期成功率的提高和风险的降低,该手术已变得更加常见且实施得更为频繁。与接受透析的患者相比,胰肾联合移植在死亡率、生活质量和糖尿病并发症方面具有明显优势。由于可以进行活体供肾移植,且通过10年随访可能有相似的患者和移植物存活率,因此应考虑该手术。肾移植后进行胰腺移植若成功,与单纯肾移植相比可改善微血管并发症,但即刻死亡率可能更高。单独胰腺移植可改善部分患者的生活质量,但由于手术复杂性和免疫抑制风险,也可能增加即刻死亡风险。胰岛移植的结果与全胰腺同种异体移植所实现的更高代谢性能不同,其适用性仅限于部分成年糖尿病患者。